-
Imperial College London (ICL) and Royal Marsden Hospital (RMH) / Institute of Cancer Research (ICR). Our aim is to make minimally invasive tumour ablation safer and more effective by protecting tissues from
-
, the other partners of this project are London-based biotechnology start-up Arborea Ltd. (the industry lead) and Imperial College London (ICL). By 2050, the world will need to produce twice as much protein as
Enter an email to receive alerts for "ICL" positions